Your browser doesn't support javascript.
loading
Nanoparticle-Delivered Transforming Growth Factor-ß1 siRNA Induces PD-1 against Gastric Cancer by Transforming the Phenotype of the Tumor Immune Microenvironment.
Wu, Fenglei; Xu, Xiujuan; Li, Wei; Hong, Yidong; Lai, Huan; Zhang, Jingzhou; Wu, Xueyu; Zhou, Kangjie; Hu, Nan.
Afiliação
  • Wu F; Department of Oncology, The First Affiliated Hospital of Kangda College of Nanjing Medical University (The Affiliated Lianyungang Hospital of Xuzhou Medical University), Xuzhou 221004, China.
  • Xu X; Department of Radiation Oncology, Lianyungang Second People's Hospital (Lianyungang Cancer Hospital), Lianyungang 222023, China.
  • Li W; Center of Research Laboratory, The First Affiliated Hospital of Kangda College of Nanjing Medical University (The Affiliated Lianyungang Hospital of Xuzhou Medical University), Xuzhou 221004, China.
  • Hong Y; Department of Oncology, The First Affiliated Hospital of Kangda College of Nanjing Medical University (The Affiliated Lianyungang Hospital of Xuzhou Medical University), Xuzhou 221004, China.
  • Lai H; Department of Oncology, The First Affiliated Hospital of Kangda College of Nanjing Medical University (The Affiliated Lianyungang Hospital of Xuzhou Medical University), Xuzhou 221004, China.
  • Zhang J; Department of Oncology, The First Affiliated Hospital of Kangda College of Nanjing Medical University (The Affiliated Lianyungang Hospital of Xuzhou Medical University), Xuzhou 221004, China.
  • Wu X; Department of Oncology, The Affiliated Lianyungang Hospital of Xuzhou Medical University (The First People's Hospital of Lianyungang), Lianyungang 222002, China.
  • Zhou K; Department of Oncology, The First Affiliated Hospital of Kangda College of Nanjing Medical University (The Affiliated Lianyungang Hospital of Xuzhou Medical University), Xuzhou 221004, China.
  • Hu N; Department of Oncology, The First Affiliated Hospital of Kangda College of Nanjing Medical University (The Affiliated Lianyungang Hospital of Xuzhou Medical University), Xuzhou 221004, China.
Pharmaceuticals (Basel) ; 15(12)2022 Nov 29.
Article em En | MEDLINE | ID: mdl-36558938
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China